Obesity and the risk for premenopausal and postmenopausal breast cancer

Cancer Prevention Research

Volumn 5, Issue 4, 2012, Pages 515-521

  Anderson, Garnet L ^a   Neuhouser, Marian L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PLACEBO; RALOXIFENE; TAMOXIFEN; ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER HORMONE THERAPY; CANCER RISK; CHEMOPROPHYLAXIS; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MEASUREMENT ERROR; OBESITY; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SCREENING; SHORT SURVEY; ADOLESCENT; ADULT; AGED; BODY MASS; BREAST TUMOR; CANCER INVASION; FEMALE; GENETICS; METHODOLOGY; MIDDLE AGED; PHENOTYPE; REVIEW; RISK; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ANTICARCINOGENIC AGENTS; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; OBESITY; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; RISK;

EID: 84864855395     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0091     Document Type: Short Survey

References (48)

1. Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, et al. Incident breast cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010;126:692-702.
2. Calle E, Rodriguez C, Walker-Thurmond K, Thun M. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-38. (Pubitemid 36459468)
3. Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, et al. Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABPP-1 and STAR Breast Cancer Prevention Trials. Cancer Prev Res 2012;5:583-92.
4. DeWaard F, Baanders-Van Halewijn EA, Huizinga J. The bimodal age distribution of patients with mammary carcinoma. Cancer 1964;17:141.
5. Valaoras VG, MacMahon B, Trichopoulos D, Polychronopoulou A. Lactation and reproductive histories of breast cancer patients in greater Athens, 1965-67. Int J Cancer 1969;4:350-63.
6. White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR. Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer 2011 Nov 28. [Epub ahead of print]
7. Harris HR, Willet WC, Terry KL, Michels KB. Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst 2011;103:273-8.
8. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study. BMJ 2007;335:1134-45.
9. Ahn J, Schatzkin A, Lacey JV Jr, Albanes D, Ballard-Barbash R, Adams KF, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 2007;167:2091-100.
10. Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in Black women. Cancer Epidemiol Biomarkers Prev 2007;16:1795-802. (Pubitemid 47450509)
11. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004;111:762-71. (Pubitemid 39062901)
12. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: The Women's Health Initiative. Cancer Causes Control 2002;13:741-51. (Pubitemid 35204050)
13. John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population. Am J Epidemiol 2011;173:201-16.
14. Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, et al. A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev 2010;19:1532-44.
15. Ogundiran TO, Huo D, Adenipekun A, Campbell O, Oyesegun R, Akang E, et al. Case-control study of body size and breast cancer risk in Nigerian women. Am J Epidemiol 2010;172:682-90.
16. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:2086-92. (Pubitemid 44877030)
17. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
18. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2011;103:250-63.
19. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:454-63.
20. Rowland ML. Self-reported height and weight. Am J Clin Nutr 1990;52:1125-33.
21. Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-reported height and weight in 4808 EPIC-Oxford partcipants. Publ Health Nutr 2002;5:561-5.
22. Carroll RJ, Ruppert D, Stefanski LA, Crainiceanu CM. Linear regression and attenuation. In: Measurement error in nonlinear models: a modern perspective, 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2006. p. 41-64.
23. Prentice RL. Measurement error and results from analytic epidemiology: Dietary fat and breast cancer. J Natl Cancer Inst 1996;88:1738-47. (Pubitemid 26405011)
24. La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, et al. Body mass index and postmmenopausal breast cancer: an age-specific analysis. Br J Cancer 1997;75:441-4. (Pubitemid 27051064)
25. Fontaine KR, Heo M, Allison DB. Body weight and cancer screening among women. J Womens Health Gend Based Med 2001;10:463-70. (Pubitemid 32677645)
26. Zhu K, Wu H, Jatoi I, Potter J, Shriver C. Body mass index and use of mammography screening in the United States. Prev Med 2006;42:381-5. (Pubitemid 44251064)
27. Littman AJ, Koepsell TD, Forsberg CW, Boyko EJ, Yancy WS. Preventive care in relation to obesity: an analysis of a large, national survey. Am J Prev Med 2011;41:465-72.
28. Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening. J Gen Intern Med 2004;19:324-31.
29. Maruther NM, Bolen S, Brancati FL, Clark JM. Obesity and mamography: a systematic review and meta-analysis. J Gen Intern Med 2009;24:665-77.
30. Berz D, Sikov W, Colvin G, Weitzen S. "Weighing in" on screening mammography. Breast Cancer Res Treat 2009;114:569-74.
31. Althius MD, Dozier JM, Anderson WF, Devessa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005;34:405-12. (Pubitemid 40645331)
32. Waller M, Moss S, Watson J, Moller H. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev 2007;16:2257-61. (Pubitemid 351196357)
33. Joffe MM, Byrne C, Colditz GA. Postmenopausal hormone use, screening and breast cancer characterization and control of a bias. Epidemiology 2001;12:429-38. (Pubitemid 32566485)
34. Weiss NS. Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it. Am J Epidemiol 2003;157:957-61. (Pubitemid 36628796)
35. Joffe MM. Invited Commentary: Screening as a nuisance variable in cancer epidemiology: methodological considerations. Am J Epidemiol 2003;157:962-4. (Pubitemid 36628797)
36. Manders P, Pijpe A, Hooning MJ, Kluijt I, Vasen HF, Hoogerbrugge N, et al. Body weight and risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2011;126:193-202.
37. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. JAMA 2003;289:3243-53. (Pubitemid 37430077)
38. Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006;295:1647-57.
39. Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomized placebo-controlled Trial. Lancet Oncology 2012 March 7. [Epub ahead of print]
40. Fisher B, Constantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998;89:1371-88. (Pubitemid 28439961)
41. Vogel BG, Costantino JP, Widkerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295:2727-41.
42. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, et al. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol 2010;22:281-8.
43. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation and insulin resistance. Gastroenterology 2007;132:2169-80.
44. Dizdar O, Alyamac E. Obesity: an endocrine tumor? Medical Hypotheses 2004;63:790-2. (Pubitemid 39369997)
45. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res 2011;4:329-46.
46. Cramer DW, Olivera JF. Epidemiologi perspective on immune-surveillance in cancer. Curr Opin Immunol 2011;23:265-71.
47. Morris PG, Hudis DA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 2011;4:1021-9.
48. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91. (Pubitemid 39025053)